|
Investigation: visual inspection: during the investigation, incrustations on the catheter were determined.Furthermore, a deformation of the outer housing of the progav valve could be determined.The measurement of the plane parallelism could confirm that with a value of -0,028 mm - outside tolerance (0 ± 0.02 mm).Permeability test: a permeability test has indicated that the progav valve has a blockage and that the shuntassistant is permeable.Computer controlled test: to investigate the claim of over- drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.Because the progav valve is not permeable, a computer-controlled test is not possible.The results show that the shuntassistant is operating not within the specified tolerances in the vertical position.An accelerated outflow of the shuntassistant could be determined.Adjustment test: the progav was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function is operational; however, the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, deposits were found in both valves.Results: based on our investigation results, we can determine a blockage and a non-adjustability in the progav valve and an accelerated outflow in the shuntassistant.The determined deposits can be named as the cause for the functional deviations.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|